Replies to post #14953 on Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

It was the guidance Newbie. That is what everyone is screaming at. The results for Q4 were quite good, but the guidance for 2022 is a disaster of epic proportions.

You have a good moniker by the way..